u/Imtooyoungg

I contacted UNCY IR and their MD Kevin Gardner replied with a B Riley research note

It states: Inspection formally assigned with management's timeline pointing to Q3/4 approval. And that FDA has communicated this in writing to the vendor - "expected to occur in weeks"

Anyone else get this response? Does seem optimistic... at least there are plans to move things forward